Clinical Trial: Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant

U.S., July 7 -- ClinicalTrials.gov registry received information related to the study (NCT07685353) titled 'Influence of Donor and Recipient Genetic Polymorphisms on Graft Steatosis After Liver Transplant' on June 29.

Brief Summary: MASH (Metabolic Dysfunction-associated Steatohepatitis) is among the most common indications for liver transplantation.The metabolic syndrome persists after liver transplant and is often further exacerbated among MAFLD patients, thereby leading to recurrence of MAFLD in the allograft. MAFLD is a complex phenotype, dynamic interactions between both genetic and environmental factors are likely to shape disease susceptibility and progression.

Genetic and epidemiological studies, indicates strong heritability of h...